PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Faculty of Medicine, Beni-Suef University, Beni Suef 62511, Egypt.\', \'Birmingham Children\'s Hospital, Birmingham B4 6NH, UK.\', \'Sinodos Chemistry Company (SinodosChemistry.com), Tenedou 16 str, 54453 Thessaloniki, Greece.\', \'Instituto de Biotecnología, UNAM (ibt.unam.mx), 62210 Cuernavaca, Mexico.\', \'Faculty of Medicine, Cairo University, Giza 11562, Egypt.\', \'Jaqui Hodgkinson Communications, 3722JK Bilthoven, The Netherlands.\', \'Essex Cardiothoracic Centre, MSE Foundation Trust, Basildon SS16 5NL, UK.\', \'Faculty of Medicine, Fayoum University, Faiyum 63514, Egypt.\', \'Aberdeen Royal Infirmary Hospital, Aberdeen AB25 2ZN, UK.\', \'Cambridge University Hospital, Cambridge CB2 0QQ, UK.\', \'Leeds General Infirmary Hospital, Leeds LS1 3EX, UK.\', \'Imam Abdulrahman Bin Faisal University Hospital, University of Dammam, Dammam 34221, Saudi Arabia.\', \'National Cancer Institute, Cairo University, Giza 11796, Egypt.\']
?:citedBy
  • -1
?:creator
?:doi
  • 297710.3390/ijms22062977
?:doi
?:hasPublicationType
?:journal
  • International journal of molecular sciences
is ?:pmid of
?:pmid
?:pmid
  • 33804129
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.26
?:rankingScore_hIndex
  • 95
is ?:relation_isRelatedTo_publication of
?:title
  • Metal-Bound Methisazone; Novel Drugs Targeting Prophylaxis and Treatment of SARS-CoV-2, a Molecular Docking Study.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all